Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Advancing Digital Health Strategy

April 27th, 2026 1:22 PM
By: Newsworthy Staff

Catalyst Crew Technologies Corp. announced its CEO will attend HLTH Europe 2026 to support strategic initiatives in digital health and AI, potentially expanding its telehealth platform in emerging markets.

Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Advancing Digital Health Strategy

Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that Dr. Kevin Rodan Levy, its Chief Executive Officer, plans to attend HLTH Europe 2026. The conference, scheduled for June 15-18 in Amsterdam, focuses on digital health, healthcare innovation, and emerging technologies.

Dr. Levy's attendance is intended to support the Company's broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships. The Company believes that participation in major international healthcare conferences provides valuable opportunities to observe industry developments, strengthen professional networks, and support its efforts to advance its telehealth and AI healthcare platform strategy.

HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from across global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery. The Company views this as an opportunity to observe industry trends and engage with broader healthcare innovation trends.

Dr. Levy stated: “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”

Catalyst Crew Technologies is an AI-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is executing its strategic transition into AI-enabled healthcare, pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.

For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Source Statement

This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,

blockchain registration record for the source press release.
;